ASSOCIATION BETWEEN PSORIASIS AND DEMENTIA: A SYSTEMATIC REVIEW

  • Magdalena Domisiewicz Department of Dermatology, Regional Hospital, Institute of Medical Sciences, University of Opole, Opole, Poland https://orcid.org/0009-0004-1158-9276
  • Kacper Domisiewicz Department of Neurosurgery, The St. Hedwig’s Regional Specialist Hospital, Opole, Poland
Keywords: Psoriasis, Dementia, Alzheimer’s Disease, Inflammation, Cognitive Impairment

Abstract

Background: Psoriasis is a chronic immune-mediated skin disease characterized by systemic inflammation, while dementia, including Alzheimer’s disease (AD) and vascular dementia, is increasingly recognized as an inflammatory neurodegenerative condition. Both disorders share common risk factors such as age, cardiovascular comorbidity, and metabolic disease. Whether psoriasis independently increases dementia risk remains unclear.

Objectives: To systematically evaluate the epidemiologic association between psoriasis and dementia, explore potential causality using genetic approaches, and assess the impact of systemic therapies, particularly biologics, on cognitive outcomes.

Methods: Following PRISMA guidelines, PubMed was searched for studies published between 2013 and 2025. Eligible studies included observational cohorts, case-control analyses, and Mendelian randomization studies examining dementia outcomes in patients with psoriasis. Data extraction was performed independently by two reviewers.

Results: Epidemiologic evidence from Taiwan, Korea, Denmark, and the UK suggests a modestly increased risk of dementia in psoriasis (odds ratios 1.10–1.25), with higher estimates in younger patients and for vascular subtypes. However, findings were inconsistent, with some cohorts reporting null or protective associations. Notably, systemic and biologic therapies were consistently associated with reduced dementia incidence. Mendelian randomization studies found no genetic evidence supporting psoriasis as a causal risk factor for AD, suggesting shared inflammatory and vascular pathways rather than direct causality.

Conclusions: Psoriasis may modestly increase dementia risk through systemic inflammation and comorbid vascular disease, rather than genetic liability. Systemic therapies, particularly biologics targeting TNF-α and IL-12/23, may confer neuroprotective benefits. Further prospective studies are warranted to clarify causality and therapeutic implications.

References

Zhao, J., Li, T., & Wang, J. (2024). Association between psoriasis and dementia: A systematic review. Neurologia, 39(1), 55–62. https://doi.org/10.1016/j.nrleng.2023.12.005

Lin, C. C., Lin, H. C., & Chiu, H. W. (2019). Association between psoriasis and dementia: A population-based case-control study. American Journal of Clinical Dermatology, 20(3), 457–463. https://doi.org/10.1007/s40257-018-00420-8

Huang, K. L., Yeh, C. C., Wu, S. I., Shen, C. C., Hu, L. Y., Tsai, S. J., & Chen, M. H. (2019). Risk of dementia among individuals with psoriasis: A nationwide population-based cohort study in Taiwan. Journal of Clinical Psychiatry, 80(3), 18m12462. https://doi.org/10.4088/JCP.18m12462

Kim, M., Park, H. E., Lee, S. H., Han, K., & Lee, J. H. (2019). Increased risk of Alzheimer’s disease in patients with psoriasis: A nationwide population-based cohort study. Journal of Clinical Medicine, 8(1), 71. https://doi.org/10.3390/jcm8010071

Leisner, M. Z., Riis, J. L., Schwartz, S., Iversen, L., Østergaard, S. D., & Olsen, M. S. (2019). Psoriasis and risk of mental disorders in Denmark. JAMA Dermatology, 155(6), 745–747. https://doi.org/10.1001/jamadermatol.2019.0162

Pezzolo, E., Mutlu, U., Vernooij, M. W., Dowlatshahi, E. A., Gisondi, P., Girolomoni, G., & Ikram, M. A. (2018). Psoriasis is not associated with cognition, brain imaging markers and risk of dementia: The Rotterdam Study. Journal of the American Academy of Dermatology, 79(5), 889–896. https://doi.org/10.1016/j.jaad.2018.07.006

Wotton, C. J., & Goldacre, M. J. (2017). Associations between specific autoimmune diseases and subsequent dementia: Retrospective record-linkage cohort study, UK. Journal of Epidemiology & Community Health, 71(6), 576–583. https://doi.org/10.1136/jech-2016-207809

Yeung, C. H. C., Au Yeung, S. L., & Schooling, C. M. (2022). Association of autoimmune diseases with Alzheimer's disease: A mendelian randomization study. Journal of psychiatric research, 155, 550–558. https://doi.org/10.1016/j.jpsychires.2022.09.052

Zhang, H., Zhang, D., Tang, K., & Sun, Q. (2021). The Relationship Between Alzheimer's Disease and Skin Diseases: A Review. Clinical, cosmetic and investigational dermatology, 14, 1551–1560. https://doi.org/10.2147/CCID.S322530

Views:

16

Downloads:

10

Published
2025-09-30
Citations
How to Cite
Magdalena Domisiewicz, & Kacper Domisiewicz. (2025). ASSOCIATION BETWEEN PSORIASIS AND DEMENTIA: A SYSTEMATIC REVIEW. International Journal of Innovative Technologies in Social Science, 6(3(47). https://doi.org/10.31435/ijitss.3(47).2025.4050